Neudle.com: Parkinson disease off time

Differential
(Click to cross reference)

abdominal protrusion

acromegaly

activities of daily living

adolescent medicine

adrenal medullary tissue

advances in neurology

adverse drug reaction

affect, flat

agitation

akinetic mute

alcohol, neurologic complications with

alternating hemiplegia

alternating hemiplegia of childhood

Alzheimer's disease

Alzheimer's disease, misdiagnosis

amantadine

amnesia

amnesia, concussion

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

anemia, iron deficiency

anesthesia, general

aneurysm, intracranial

angiography, cerebral

animal exposure

anti basal ganglia antibodies

anti IgLON5

antibiotics, neurologic complications with

anticholinergic drugs

anticoagulant, complications of

anticoagulant, treatment

aphasia, progressive, primary

apomorphine

apraxia

apraxia of eyelid opening

apraxia, constructional

arbovirus

areflexia

arteriovenous malformation, brainstem

attention deficit disorder with hyperactivity

attention span

atypical

auditory and vestibular pathways

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autoimmune GFAP astrocytopathy

autonomic dysfunction

axonal degeneration

Babinski sign

basal ganglia

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

benign essential tremor, refractory

benserazide

bilirubin encephalopathy

brain transplantation

brain transplantation, complications of

brainstem, lesion of

brainstem, vascular malformation of

carbon monoxide poisoning

CAT scan, angiography

CAT scan, angiography, false negative

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, stereotactic localization

CAT scan, venography

cataplexy

catechol-o-methyltransferase inhibitor

cavernous hemangioma

central hypoventilation

centrum semiovale

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar edema

cerebellar hemorrhage

cerebellar lesion

cerebellar vermis

cerebellitis

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, complications with

cerebrovascular accident, nonarterial territory

ceruloplasmin, serum

chemotherapy, CNS treatment and complications with

chromosomal abnormality

chromosome 14

chromosome 17

cingulate island sign

cirrhosis

climate change

Clinical Pathologic Conference(C.P.C.)

computers, medicine and

controversies in neurology

conversion reaction

copper metabolism, abnormal

coprolalia

corpus callosum, lesion of

corpus callosum, thinning

cortical blindness

cortical infarction

cortical-basal ganglionic degeneration

cost effectiveness

cough

CPAP

cranial nerve palsies

cranial neuropathy

craniotomy

creatine phosphokinase(CPK)elevated

Cushing's syndrome

DATATOP study

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, posttraumatic

dementia, presenile

dementia, rapidly progressive

dementia, thalamic

demyelinating disease

deprenyl

depression

developmental milestones, loss of

developmental retardation

developmental venous anomalies

dexamethasone suppression test

dexterity, impaired

diabetes dialysis basal ganglia syndrome

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diagnostic criteria

dialysis

diet

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disorientation

distal muscle atrophy

diurnal variation

dizziness

dopa responsive dystonia

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine receptor, D2

drug abuse

drug abuse, neurologic complications of

drug induced neurologic disorders

drug interactions

drug overdose

drug withdrawal

dural arteriovenous malformation

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, cervical

dystonia, children

dystonia, drug induced

dystonia, etiology of

dystonia, focal

dystonia, painful

dystonia, psychogenic

dystonia, segmental

dystonia, treatment of

DYT1 mutation

efficacy

electroencephalogram

electroencephalogram, abnormalities of

electron microscopy

emergencies, neurologic

encephalitis

encephalitis lethargica

encephalitis, brainstem

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy

encephalopathy, delayed

encephalopathy, neonatal

encephalopathy, post anoxic

encephalopathy, progressive

epidemiology of neurology

epistaxis

erectile dysfunction

evidence-based research

executive dysfunction

exome sequencing

eye movement, disorders of

facial nerve palsy

facial weakness

failed medical management

fever of unknown origin

fibrinolytic agents

fibrinolytic agents, complications

fingerprint bodies

fistula, arterio-venous, dural

flavivirus

fluency

flushing

follicle stimulating hormone

foot deformity

fourth ventricle, compression

fracture, long bone

frontal behavioral spatial syndrome

frontal lobe, behavior with disease of

frontal lobe, pathologic signs of

frontotemporal dementia, behavioral variant

gammaglobulin therapy, intravenous

gastrostomy

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus focused ultrasound ablation

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

globus pallidus, stimulation

glutamic acid decarboxylase, antibody

grasp reflex

growth hormone

guanfacine

Hallervorden Spatz disease

head injury, brain stem lesion after

head injury, prognosis in

head injury, severe

headache

hearing loss

hemangioma, brainstem

hemorrhagic diathesis

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatolenticular degeneration, non-Wilsonian

hepatomegaly

hepatosplenomegaly

heralding manifestation

herniation syndromes, intracranial

HLA

hoarseness

human immunodeficiency virus type 1

hummingbird sign

hunger

hydrocephalus

hyperammonemic encephalopathy

hyperbilirubinemia

hyperbilirubinemia, CNS abnormality after

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

hypotonia

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion bodies, location of

incontinence, fecal

inflexibility, mental

insect sting

insomnia

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, incidence of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, recurrent

intracerebral hemorrhage, treatment of

intracranial hypotension

intranasal medication

intravenous

iron supplementation

iron, brain

Jakob-Creutzfeldt disease

jaundice

Kayser-Fleischer ring

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, plasma concentration

L-dopa, potentiators of

leg spasms

leg spasms, painful

lenticular nucleus, lesion of

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

liver function enzymes

lobar atrophy

logopenia

loss of sympathy

lumbar puncture, complications of

luteinizing hormone

madopar

malformation, vascular

malformation, vascular, cerebral

manganese intoxication

marche a petits pas

masked facies

medical-legal aspects of neurology

medication withdrawal

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, carcinomatous

meningoencephalitis

meningoencephalomyelitis

mental status, abnormal

microhemorrhage, intracerebral

microsurgery

microsurgery, transsphenoidal

migratory lesion pattern

mimics

minimally invasive surgery

misdiagnosis

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI, angiography, false negative

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, mass effect on

MRI, negative

MRI, paramagnetic effect

MRI, ring sign

MRI, serial

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

MRI, venography

multiple sclerosis

multiple sclerosis, misdiagnosis

multiple system atrophy

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-hemorrhage into

neoplasm, metastatic to CNS-multiple

neoplasm, metastatic to CNS-prognosis of

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-hemorrhage in

neurodegeneration with brain iron accumulation

neuroendocrinology

neurofilament light chain protein

neurofilaments

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic symptoms

neuronal ceroid-lipofuscinosis

neuronal intranuclear inclusion disease

neuronopathy

neuronopathy, sensory

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

neuroprotective agents

obsessive-compulsive disorder

occupational neurologic disorders

octreotide

ocular motility, disorders of

oculogyric crisis

olanzapine

old age, neurology of

ophthalmoplegia

ophthalmoplegia, progressive external

ophthalmoplegia, total

opsoclonus

optic atrophy

organomegaly

orthostatic hypotension

outcome research

owl's eye sign of spinal cord

pain

pain, increased response

Parkinson disease, atypical

Parkinson disease, benign tremulous

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, intractable

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

paroxysmal hemiplegia

paroxysmal neurologic deficits

pathology

patient information and support

penicillamine

pergolide

persistent vegetative state

personality change

phenothiazine

PHNO

PHNO, enteral infusion, continuous

pituitary, enlargement

pituitary, hormones of

pituitary, microadenoma

pleocytosis of cerebrospinal fluid

POLG1 gene

polyneuropathy

polypharmacy

polyps, gastrointestinal tract

portal caval shunt

posterior fossa, lesion of

posterior fossa, mass of

postural abnormality

practice guidelines

pramipexole

precipitating factors

preclinical

pregabalin

pregnancy, neurologic complications in

premature infant

prevention of neurologic disorders

primary intracranial hypotension

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychomotor retardation

pupil, dilated, bilateral

putamen, lesion of

putamen, lesion of, bilateral

pyramidal tract dysfunction

pyridoxine

quality of life

quetiapine

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

rasagiline

reaction time

reading disorder, acquired

reading problem, causes of

reserpine and reserpine like drugs

respirations in CNS disease

respiratory failure

restless leg syndrome

retina, abnormal

retinitis pigmentosa

reversible neurologic disorder

risk-benefit assessment

risperidone

rodents

ropinirole

ropinirole, prolonged release

Russia

saccadic eye movements

saccadic eye movements, abnormal

safety

sagging of the brain

salivation, excessive

sedimentation rate, elevated

seizure

seizure, intractable

seizure, laughing as manifestation

selective serotonin reuptake inhibitors

sensorineural hearing loss

serologic testing

serotonin

serotonin syndrome

serum glutamic oxaloacetic transaminase

serum glutamic pyruvic transaminase

single photon emission computed tomography

skin, biopsy

sleep

sleep apnea, obstructive

sleep pathology and physiology

smell

SNCA duplication

somatostatin analogue

somnolence

speech disorder

speech disorder, childhood

speech, soft

spinal cord, lesion of

spinocerebellar ataxia type 1

splenomegaly

sports medicine, neurology of

standing difficulty

stare

status epilepticus

stem cell transplantation

stereotaxic surgery

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

stimulant drugs

stimulation, deep brain

stimulation, deep brain, bilateral

stimulation, sensory

stress, emotional

striatonigral degeneration

stridor

strokelike episodes

subarachnoid hemorrhage

subdural hematoma

subdural hematoma, acute

substantia nigra

substantia nigra tissue

subthalamic nucleus

subthalamic nucleus deep brain stimulation

suicide

sweating

symmetric brain lesions

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, atrophy

term infant

thalamotomy

thalamus, focused ultrasound ablation

thalamus, lesion of

thalamus, lesion of-bilateral

tic

tic, classification of

tick-borne encephalitis

toe walking

tolcapone

tonic foot response

tonsillar herniation of cerebellum

toxoplasmosis, CNS

tracheostomy

treatment of neurologic disorder

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tremulousness

tricyclic antidepressant

trientine dihydrochloride

trigeminal neuralgia

tripping

twins

tyrosine hydroxylase deficiency

ultrasonography

ultrasonography, head

Unified Parkinson Rating Scale

ventricular obstruction

vision, failure of in childhood

visual acuity, decreased

visual field defect

visual impairment

visual loss

visual loss, progressive

visual loss, slow

visuospatial disturbance

walking, difficulty with

weakness

weakness, progressive

white matter disease, periventricular

whole genome sequencing

wide based gait

Wolff-Parkinson-White syndrome

word-finding difficulty

workup

Showing articles 150 to 200 of 5966 << Previous Next >>

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Protein Redistribution Diet Remains Effective in Patients with Fluctuating Parkinsonism
Arch Neurol 49:149-151, Karstaedt,P.J.&Pincus,J.H., 1992

Managing the Persistent Vegetative State, Early, Skilled Treatment Offers the Best Hope for Optimal Recovery
BMJ 305:486-487, Andrews,K., 1992

Delayed Encephalopathy after Acute Carbon Monoxide Intoxication:MR Imaging Features & Cerebral White Matter Lesions
Radiology 184:117-122, Chang,K.H.,et al, 1992

Intranasal Apomorphine in Parkinsonian On-Off Fluctuations
Arch Neurol 49:482-484, vanLaar,T.,et al, 1992

United Parkinson Foundation Neurotransplantation Registry on Adrenal Medullary Transplants:Presurg, & 1-and 2-yr Follow-up
Neurol 41:1719-1722, Goetz,C.G.,et al, 1991

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991

Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991

Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991

Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991

Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991

Intranasal Apomorphine in Parkinson's Disease
Neurol 41:761-762, Kleedorfer,B.,et al, 1991

Wilson's Disease
In Oxford Textbook of Clin Hepatology, Oxford Univ Press, Vol 2, Ch 20. 1, p. 947, Sternlieb,I.&Scheinberg,I.H., 1991

Autologous Transplantation of Adrenal Medulla in Parkinson's Disease, 18-Mo Results
Arch Neurol 47:1286-1289, Olanow,C.W.,et al, 1990

Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990

The Changing Patterns of Death Rates in Parkinsonism
Neurol 40:42-49, Kurtzke,J.F.&Murphy,F.M., 1990

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

Two Decades of Increasing Mortality from Parkinson's Disease Among the US Elderly
Arch Neurol 47:731-734, Lilienfeld,D.E.,et al, 1990

Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989

Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989

The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989

Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988

Protein Redistribution Diet Restores Motor Function in Patients with Dopa-Resistant"Off"Periods
Neurol 38:481-483, Pincus,J.H.&Barry,K., 1988

Long-Term Duodenal Infusion of Levodopa for Motor Fluctuations in Parkinsonism
Ann Neurol 24:87-89, Sage,J.I.,et al, 1988

Hemiparkinsonism with Hemiatrophy
Neurol 38:527-530, Buchman,A.S.,et al, 1988

Parkinsonism Death Rates by Race, Sex, and Geography
Neurol 38:1558-1561, Kurtzke,J.F.&Goldberg,I.D., 1988

Risk Factors for Progression in Parkinson's Disease
Neurol 38:1841-1844, Goetz,C.G.,et al, 1988

Neurologic Aspects of Boxing
Arch Neurol 44:453-459, Jordan,B.D., 1987

Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987

Reaction Times & Attention in Parkinson's Disease
JNNP 50:1178-1183, Bloxham,C.A.,et al, 1987

The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986

Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986

The"On-Off"Phenomenon in Parkinson's Disease
NEJM 310:483-488, Nutt,J.G.,et al, 1984

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Treatment of the"On-Off"Phenomenon Parkinsonism with Lithium Carbonate
Ann Neurol 12:375-379, Coffey,C.E.,et al, 1982

Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979

Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979

Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979

The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

An 81-Year-Old Man with Imbalance and Memory Impairment
, Golbe,L.I.,et al,

Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026

Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026

Association of Changes in Activity Patterns with Brain Atrophy and Disability Progression in People with Multiple Sclerosis
Neurol 106:e214678, e214742, Fitzgerald,K.C.,et al, 2026

Clinical Insights Into CASPR1 and CASPR1/Contactin1 Com-lex Autoimmune Nodopathies
Neurol 106:e214403, Paramasivan,N.K.,et al, 2026

Clinicopathologic Conference, Disseminated Infection with Hypervirulent Klebsiella Pneumoniae
NEJM 394:282-294, Case 202026, 2026

Showing articles 150 to 200 of 5966 << Previous Next >>